Ulge Umut 13D and 13G filings for Neoleukin Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-11 4:06 pm Purchase |
2021-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Ulge Umut | 156,387 7.300% |
9,115 (+6.19%) |
Filing |
| 2021-02-12 4:27 pm Sale |
2020-12-31 | 13G | Neoleukin Therapeutics, Inc. NLTX |
Ulge Umut | 147,272 6.980% |
-8,323 (-5.35%) |
Filing |